A genetically modified allogeneic cellular vaccine generates MHC class I-restricted cytotoxic responses against tumor-associated antigens and protects against CNS tumors in vivo.

Source:http://linkedlifedata.com/resource/pubmed/id/9307226

Download in:

View as

General Info

PMID
9307226